Login / Signup

Breast carcinoma with 21-gene recurrence score lower than 18: rate of locoregional recurrence in a large series with clinical follow-up.

Gulisa TurashviliEdi BrogiMonica MorrowMaura DicklerLarry NortonClifford HudisHannah Y Wen
Published in: BMC cancer (2018)
Our study of node negative, ER+/HER2- breast cancer patients with low RS observed extremely low rates of LRR: 0.9% (13/1396) in the whole cohort and 0.7% (8/1184) in patients treated with endocrine therapy alone. As the largest series to date, we report detailed clinicopathologic data and clinical outcomes of this cohort and provide a comprehensive characterization of patients who developed LRR.
Keyphrases
  • free survival
  • lymph node
  • genome wide
  • electronic health record
  • copy number
  • big data
  • stem cells
  • gene expression
  • estrogen receptor
  • endoplasmic reticulum
  • young adults
  • mesenchymal stem cells
  • cell therapy
  • data analysis